Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_assertion type Assertion NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_head.
- NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_assertion description "[There is evidence that the obesity phenotype in the Caucasian populations is associated with variations in several genes, including neuronal growth regulator 1 (NEGR1), SEC16 homolog B (SCE16B), transmembrane protein 18 (TMEM18), ets variant 5 (ETV5), glucosamine-6-phosphate deaminase 2 (GNPDA2), prolactin (PRL), brain-derived neurotrophic factor (BDNF), mitochondrial carrier homolog 2 (MTCH2), Fas apoptotic inhibitory molecule 2 (FAIM2), SH2B adaptor protein 1 (SH2B1), v-maf musculoaponeurotic fibrosarcoma oncogene homolog (MAF), Niemann-Pick disease, type C1 (NPC1), melanocortin 4 receptor (MC4R) and potassium channel tetramerisation domain containing 15 (KCTD15).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_provenance.
- NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_assertion evidence source_evidence_literature NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_provenance.
- NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_assertion SIO_000772 19851340 NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_provenance.
- NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_assertion wasDerivedFrom gad-20150221 NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_provenance.
- NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_assertion wasGeneratedBy ECO_0000203 NP108725.RA4emU7sKkjQILfPSILuQElHtG5tj-Kgl5uJpQXnls-u0130_provenance.